ArticleHuman vaccines & immunotherapeutics2026
Meningococcal vaccine information on YouTube in Türkiye: A cross-sectional analysis of content quality and reliability.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meningococcal infections represent a significant public health concern due to their high mortality and morbidity rates. In Turkey, meningococcal vaccines are not included in the routine immunization schedule, and families increasingly seek health-related information through digital platforms. YouTube, as a widely used video-sharing platform, has the potential to influence public attitudes toward vaccination; however, concerns remain regarding the reliability and quality of its content. This study aimed to evaluate the characteristics and quality of YouTube videos related to meningococcal vaccines in Turkey. This cross-sectional study analyzed 158 YouTube videos retrieved using the keywords "meningococcal vaccines" and "private vaccines." Videos were evaluated according to uploader type, content features, message tone, and audio-visual quality. The Global Quality Scale (GQS) and the Journal of the American Medical Association (JAMA) benchmark criteria were used for quality assessment. Of the videos, 55.7% were uploaded by physicians and 92.4% were intended for patient education. Most videos (86.7%) conveyed positive messages about vaccination. Physician-produced videos demonstrated significantly higher quality scores, while videos uploaded by pharmaceutical companies were more up-to-date and had higher view counts. Overall, a considerable proportion of the videos were of moderate or low quality. The quality and reliability of YouTube content on meningococcal vaccines vary substantially. Increasing the availability of evidence-based, high-quality content and encouraging greater involvement of healthcare professionals in digital media are essential to support informed vaccination decisions and reduce vaccine hesitancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.